Canada markets closed

Verve Therapeutics, Inc. (VERV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.41+0.26 (+4.23%)
At close: 04:00PM EDT
6.41 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
11,758
11,758
1,941
0
0
Operating Expenses
Research Development
184,946
184,946
130,095
68,202
35,371
Selling General and Administrative
49,936
49,936
37,533
18,865
5,256
Total Operating Expenses
234,882
234,882
167,628
87,067
40,627
Operating Income or Loss
-223,124
-223,124
-165,687
-87,067
-40,627
Total Other Income/Expenses Net
165
165
1,486
-33,389
-5,239
Income Before Tax
-199,793
-199,793
-157,334
-120,314
-45,704
Income Tax Expense
275
275
53
0
0
Income from Continuing Operations
-200,068
-200,068
-157,387
-120,314
-45,704
Net Income
-200,068
-200,068
-157,387
-120,314
-45,704
Net Income available to common shareholders
-200,068
-200,068
-157,387
-120,314
-45,704
Basic EPS
-3.08
-
-2.91
-4.48
-2.58
Diluted EPS
-3.08
-
-2.91
-4.48
-2.58
Basic Average Shares
62,129
-
54,024
26,872
17,739
Diluted Average Shares
63,737
-
54,024
26,872
17,739